Mesenchymal stem cell signaling in cancer progression

Cancer Treatment Reviews

Volumn 39, Issue 2, 2013, Pages 180-188

  Torsvik, Anja ^a   Bjerkvig, Rolf ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

Cancer; Mesenchymal stem cells; PI3K Akt pathway; Tumor microenvironment; Tumor stroma

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ESTROGEN RECEPTOR; INTERLEUKIN 6 RECEPTOR; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1; TYROSINE KINASE RECEPTOR; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; BURKITT LYMPHOMA; CANCER GROWTH; CANCER INVASION; CANCER STEM CELL; CELL CYCLE ARREST; CELL DEATH; CELL INTERACTION; CELL MIGRATION; CELL STIMULATION; CELL SURVIVAL; CHRONIC MYELOID LEUKEMIA; COLORECTAL CARCINOMA; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; GLIOBLASTOMA; HUMAN; INTRACELLULAR SIGNALING; LIVER CELL CARCINOMA; LUNG CANCER; MESENCHYMAL STEM CELL; METASTASIS; MOLECULAR INTERACTION; NATURAL KILLER CELL; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CELL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; STROMA; TUMOR CELL; TUMOR GROWTH;

ANIMALS; CELL COMMUNICATION; CELL PROLIFERATION; DISEASE PROGRESSION; HUMANS; MESENCHYMAL STROMAL CELLS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84869491266     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2012.03.005     Document Type: Review

References (102)

1. Houghton J., Stoicov C., Nomura S., et al. Gastric cancer originating from bone marrow-derived cells. Science 2004, 306(5701):1568-1571.
2. Tirode F., Laud-Duval K., Prieur A., et al. Mesenchymal stem cell features of Ewing tumors. Cancer Cell 2007, 11(5):421-429.
3. Matushansky I., Hernando E., Socci N.D., et al. Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. J Clin Invest 2007, 117(11):3248-3257.
4. Mohseny A.B., Szuhai K., Romeo S., et al. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2. J Pathol 2009, 219(3):294-305.
5. Tolar J., Nauta A.J., Osborn M.J., et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007, 25(2):371-379.
6. Rosland G.V., Svendsen A., Torsvik A., et al. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res 2009, 69(13):5331-5339.
7. Ren Z., Zhang Y.A., Chen Z. Spontaneous transformation of cynomolgus mesenchymal stem cells in vitro: further confirmation by short tandem repeat analysis. Exp Cell Res 2012, 318(5):435-440.
8. Ren Z., Wang J., Zhu W., et al. Spontaneous transformation of adult mesenchymal stem cells from cynomolgus macaques in vitro. Exp Cell Res 2011, 317(20):2950-2957.
9. Rubio D., Garcia-Castro J., Martin M.C., et al. Spontaneous human adult stem cell transformation. Cancer Res 2005, 65(8):3035-3039.
10. Wang Y., Huso D.L., Harrington J., et al. Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy 2005, 7(6):509-519.
11. Miura M., Miura Y., Padilla-Nash H.M., et al. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 2006, 24(4):1095-1103.
12. Li H., Fan X., Kovi R.C., et al. Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice. Cancer Res 2007, 67(22):10889-10898.
13. Ferrand J., Noel D., Lehours P., et al. Human bone marrow-derived stem cells acquire epithelial characteristics through fusion with gastrointestinal epithelial cells. PLoS One 2011, 6(5):e19569.
14. Torsvik A., Rosland G.V., Svendsen A., et al. Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter. Cancer Res 2010, 70(15):6393-6396.
15. Garcia S., Bernad A., Martin M.C., et al. Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. Exp Cell Res 2010, 316(9):1648-1650.
16. de la Fuente R., Bernad A., Garcia-Castro J., et al. Retraction: spontaneous human adult stem cell transformation. Cancer Res 2010, 70(16):6682.
17. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674.
18. Mueller M.M., Fusenig N.E. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004, 4(11):839-849.
19. Mishra P.J., Humeniuk R., Medina D.J., et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 2008, 68(11):4331-4339.
20. Quante M., Tu S.P., Tomita H., et al. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell 2011, 19(2):257-272.
21. Jotzu C., Alt E., Welte G., et al. Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors. Cell Oncol (Dordr) 2011, 34(1):55-67.
22. Spaeth E.L., Dembinski J.L., Sasser A.K., et al. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 2009, 4(4):e4992.
23. Wang D., Park J.S., Chu J.S., et al. Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor beta1 stimulation. J Biol Chem 2004, 279(42):43725-43734.
24. Jiang L., Gonda T.A., Gamble M.V., et al. Global hypomethylation of genomic DNA in cancer-associated myofibroblasts. Cancer Res 2008, 68(23):9900-9908.
25. Tsai K.S., Yang S.H., Lei Y.P., et al. Mesenchymal stem cells promote formation of colorectal tumors in mice. Gastroenterology 2011, 141(3):1046-1056.
26. Karnoub A.E., Dash A.B., Vo A.P., et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007, 449(7162):557-563.
27. Minguell J.J., Erices A., Conget P. Mesenchymal stem cells. Exp Biol Med (Maywood) 2001, 226(6):507-520.
28. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105(4):1815-1822.
29. Djouad F., Plence P., Bony C., et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003, 102(10):3837-3844.
30. Patel S.A., Meyer J.R., Greco S.J., et al. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. J Immunol 2010, 184(10):5885-5894.
31. Mendez-Ferrer S., Michurina T.V., Ferraro F., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466(7308):829-834.
32. Calabrese C., Poppleton H., Kocak M., et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007, 11(1):69-82.
33. Sneddon J.B., Werb Z. Location, location, location: the cancer stem cell niche. Cell Stem Cell 2007, 1(6):607-611.
34. Sneddon J.B., Zhen H.H., Montgomery K., et al. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci U S A 2006, 103(40):14842-14847.
35. Hsu H.S., Lin J.H., Hsu T.W., et al. Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway. Lung Cancer 2011, 75(2):167-177.
36. Sasser A.K., Sullivan N.J., Studebaker A.W., et al. Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer. FASEB J 2007, 21(13):3763-3770.
37. Klopp A.H., Lacerda L., Gupta A., et al. Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. PLoS One 2010, 5(8):e12180.
38. Yan X.L., Fu C.J., Chen L., et al. Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway. Breast Cancer Res Treat 2011, 132(1):153-164.
39. Muehlberg F.L., Song Y.H., Krohn A., et al. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 2009, 30(4):589-597.
40. Liu S., Ginestier C., Ou S.J., et al. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res 2011, 71(2):614-624.
41. Qiao L., Xu Z., Zhao T., et al. Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res 2008, 18(4):500-507.
42. Qiao L., Xu Z.L., Zhao T.J., et al. Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling. Cancer Lett 2008, 269(1):67-77.
43. Secchiero P., Zorzet S., Tripodo C., et al. Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts. PLoS One 2010, 5(6):e11140.
44. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140(6):883-899.
45. Corcoran K.E., Trzaska K.A., Fernandes H., et al. Mesenchymal stem cells in early entry of breast cancer into bone marrow. PLoS One 2008, 3(6):e2563.
46. Fierro F.A., Sierralta W.D., Epunan M.J., et al. Marrow-derived mesenchymal stem cells: role in epithelial tumor cell determination. Clin Exp Metastasis 2004, 21(4):313-319.
47. Rhodes L.V., Muir S.E., Elliott S., et al. Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence. Breast Cancer Res Treat 2010, 121(2):293-300.
48. Sasser A.K., Mundy B.L., Smith K.M., et al. Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments. Cancer Lett 2007, 254(2):255-264.
49. Bian Z.Y., Fan Q.M., Li G., et al. Human mesenchymal stem cells promote growth of osteosarcoma: involvement of interleukin-6 in the interaction between human mesenchymal stem cells and Saos-2. Cancer Sci 2010, 101(12):2554-2560.
50. Xu W.T., Bian Z.Y., Fan Q.M., et al. Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis. Cancer Lett 2009, 281(1):32-41.
51. Kucerova L., Matuskova M., Hlubinova K., et al. Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer 2010, 9:129.
52. Studeny M., Marini F.C., Dembinski J.L., et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 2004, 96(21):1593-1603.
53. Ignatov A., Robert J., Gregory-Evans C., et al. RANTES stimulates Ca2+ mobilization and inositol trisphosphate (IP3) formation in cells transfected with G protein-coupled receptor 75. Br J Pharmacol 2006, 149(5):490-497.
54. Barbero S., Bonavia R., Bajetto A., et al. Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 2003, 63(8):1969-1974.
55. Khakoo A.Y., Pati S., Anderson S.A., et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 2006, 203(5):1235-1247.
56. Yu J.M., Jun E.S., Bae Y.C., et al. Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev 2008, 17(3):463-473.
57. Rhodes L.V., Short S.P., Neel N.F., et al. Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. Cancer Res 2010, 71(2):603-613.
58. Loi S., Haibe-Kains B., Majjaj S., et al. PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer. Proc Natl Acad Sci U S A 2010, 107(22):10208-10213.
59. Razmkhah M., Jaberipour M., Erfani N., et al. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-beta1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response?. Cell Immunol 2011, 266(2):116-122.
60. Hung S.C., Pochampally R.R., Chen S.C., et al. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 2007, 25(9):2363-2370.
61. Lin G., Yang R., Banie L., et al. Effects of transplantation of adipose tissue-derived stem cells on prostate tumor. Prostate 2010, 70(10):1066-1073.
62. Dufourcq P., Descamps B., Tojais N.F., et al. Secreted frizzled-related protein-1 enhances mesenchymal stem cell function in angiogenesis and contributes to neovessel maturation. Stem Cells 2008, 26(11):2991-3001.
63. Tian L.L., Yue W., Zhu F., et al. Human mesenchymal stem cells play a dual role on tumor cell growth in vitro and in vivo. J Cell Physiol 2011, 226(7):1860-1867.
64. Caplan A.I. All MSCs are pericytes?. Cell Stem Cell 2008, 3(3):229-230.
65. Crisan M., Yap S., Casteilla L., et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 3(3):301-313.
66. Silva G.V., Litovsky S., Assad J.A., et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005, 111(2):150-156.
67. Bexell D., Gunnarsson S., Tormin A., et al. Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol Ther 2009, 17(1):183-190.
68. Tang J., Wang J., Yang J., et al. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Eur J Cardiothorac Surg 2009, 36(4):644-650.
69. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324(5930):1029-1033.
70. Samudio I., Harmancey R., Fiegl M., et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J Clin Invest 2010, 120(1):142-156.
71. Samudio I., Fiegl M., McQueen T., et al. The warburg effect in leukemia-stroma cocultures is mediated by mitochondrial uncoupling associated with uncoupling protein 2 activation. Cancer Res 2008, 68(13):5198-5205.
72. Fritz V., Fajas L. Metabolism and proliferation share common regulatory pathways in cancer cells. Oncogene 2010, 29(31):4369-4377.
73. Dasari V.R., Kaur K., Velpula K.K., et al. Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway. PLoS One 2010, 5(4):e10350.
74. Nakamura K., Ito Y., Kawano Y., et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 2004, 11(14):1155-1164.
75. Waterman R.S., Tomchuck S.L., Henkle S.L., et al. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One 2010, 5(4):e10088.
76. Priebe A., Tan L., Wahl H., et al. Glucose deprivation activates AMPK and induces cell death through modulation of Akt in ovarian cancer cells. Gynecol Oncol 2011, 122(2):389-395.
77. Sun B., Yu K.R., Bhandari D.R., et al. Human umbilical cord blood mesenchymal stem cell-derived extracellular matrix prohibits metastatic cancer cell MDA-MB-231 proliferation. Cancer Lett 2010, 296(2):178-185.
78. Zhu Y., Sun Z., Han Q., et al. Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia 2009, 23(5):925-933.
79. Cousin B., Ravet E., Poglio S., et al. Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. PLoS One 2009, 4(7):e6278.
80. Ramasamy R., Lam E.W., Soeiro I., et al. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia 2007, 21(2):304-310.
81. Chen T.S., Lai R.C., Lee M.M., et al. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res 2010, 38(1):215-224.
82. Lim P.K., Bliss S.A., Patel S.A., et al. Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res 2011, 71(5):1550-1560.
83. Hombauer H., Minguell J.J. Selective interactions between epithelial tumour cells and bone marrow mesenchymal stem cells. Br J Cancer 2000, 82(7):1290-1296.
84. Martin F.T., Dwyer R.M., Kelly J., et al. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat 2010, 124(2):317-326.
85. Kucia M., Jankowski K., Reca R., et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 2004, 35(3):233-245.
86. Pinilla S., Alt E., Abdul Khalek F.J., et al. Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Lett 2009, 284(1):80-85.
87. Li G.C., Ye Q.H., Xue Y.H., et al. Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line. Cancer Sci 2010, 101(12):2546-2553.
88. Azari S., Ahmadi N., Tehrani M.J., et al. Profiling and authentication of human cell lines using short tandem repeat (STR) loci: report from the National Cell Bank of Iran. Biologicals 2007, 35(3):195-202.
89. Ishii N., Maier D., Merlo A., et al. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 1999, 9(3):469-479.
90. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141(1):52-67.
91. Klopp A.H., Gupta A., Spaeth E., et al. Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?. Stem Cells 2011, 29(1):11-19.
92. Noel D., Caton D., Roche S., et al. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res 2008, 314(7):1575-1584.
93. Wagner W., Wein F., Seckinger A., et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 2005, 33(11):1402-1416.
94. Goldstein R.H., Reagan M.R., Anderson K., et al. Human bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis. Cancer Res 2010, 70(24):10044-10050.
95. Doucette T., Rao G., Yang Y., et al. Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model. Neoplasia 2011, 13(8):716-725.
96. Rhodes L.V., Antoon J.W., Muir S.E., et al. Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk. Mol Cancer 2010, 9:295.
97. Roorda B.D., Elst A., Boer T.G., et al. Mesenchymal stem cells contribute to tumor cell proliferation by direct cell-cell contact interactions. Cancer Invest 2010, 28(5):526-534.
98. Ahn G.O., Brown J.M. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 2008, 13(3):193-205.
99. Du R., Lu K.V., Petritsch C., et al. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 2008, 13(3):206-220.
100. Beroukhim R., Mermel C.H., Porter D., et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010, 463(7283):899-905.
101. Lacroix M., Leclercq G. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 2004, 83(3):249-289.
102. Sipos B., Moser S., Kalthoff H., et al. A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Arch 2003, 442(5):444-452.